NasdaqCM - Delayed Quote USD
Cellectar Biosciences, Inc. (CLRB)
Tune into live earnings calls Now streaming directly on quote pages.
0.2474
-0.0041
(-1.63%)
At close: May 9 at 4:00:00 PM EDT
0.2519
+0.00
+(1.82%)
After hours: May 9 at 6:54:22 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 4 |
| Avg. Estimate | -0.16 | -0.15 | -0.64 | -0.85 |
| Low Estimate | -0.18 | -0.15 | -0.65 | -1.31 |
| High Estimate | -0.15 | -0.15 | -0.63 | -0.6 |
| Year Ago EPS | -0.74 | -0.03 | -1.22 | -0.64 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 3 | 4 |
| Avg. Estimate | -- | -- | -- | 31.1M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 124.4M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.56 | -0.27 | -0.37 | -0.35 |
| EPS Actual | -0.74 | -0.03 | -0.37 | -0.01 |
| Difference | -0.18 | 0.24 | 0 | 0.34 |
| Surprise % | -31.36% | 88.89% | 0.89% | 97.16% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.16 | -0.15 | -0.64 | -0.85 |
| 7 Days Ago | -0.19 | -0.18 | -0.68 | -0.98 |
| 30 Days Ago | -0.19 | -0.18 | -0.68 | -0.98 |
| 60 Days Ago | -0.19 | -0.18 | -0.68 | -0.98 |
| 90 Days Ago | -0.21 | -0.19 | -0.71 | -0.88 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CLRB | 77.93% | -400.00% | 47.54% | -32.81% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Downgrade | Oppenheimer: Outperform to Perform | 12/11/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 11/19/2024 |
| Maintains | Roth MKM: Buy to Buy | 3/28/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 3/28/2024 |
| Reiterates | Roth MKM: Buy to Buy | 3/4/2024 |
| Maintains | HC Wainwright & Co.: Buy | 11/4/2022 |
Related Tickers
HLVX HilleVax, Inc.
1.9000
-0.52%
SPRO Spero Therapeutics, Inc.
0.6200
+7.83%
EPIX ESSA Pharma Inc.
1.7200
+0.58%
ASMB Assembly Biosciences, Inc.
12.24
+4.97%
IPSC Century Therapeutics, Inc.
0.5370
+3.27%
ANTX AN2 Therapeutics, Inc.
1.2000
-1.64%
KZR Kezar Life Sciences, Inc.
4.2200
+2.43%
GLTO Galecto, Inc.
2.7450
-1.96%
IKNA Ikena Oncology, Inc.
1.1300
+4.63%
TBPH Theravance Biopharma, Inc.
8.98
-9.29%